Wells Fargo & Company Insulet Corp Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PODD
# of Institutions
687Shares Held
62.7MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.3 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.11 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.65 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$792 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$618 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.9B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...